Skip to main navigation Skip to search Skip to main content

Role of B-cells in mycosis fungoides

  • Pia Rude Nielsen*
  • , Jens Ole Eriksen
  • , Mia Dahl Sørensen
  • , Ulrike Wehkamp
  • , Lise Maria Lindahl
  • , Michael Bzorek
  • , Lars Iversen
  • , Anders Woetman
  • , Niels Ødum
  • , Thomas Litman
  • , Lise Mette Rahbek Gjerdrum
  • *Corresponding author for this work
  • Zealand University Hospital, Roskilde
  • Aarhus University Hospital
  • University of Copenhagen
  • University Medical Center Schleswig-Holstein

Research output: Contribution to journal › Journal article › Research › peer-review

140 Downloads (Pure)

Abstract

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma. The inflammatory microenvironment in mycosis fungoides is complex. There is accumulating evidence that the neoplastic T-cells take control of the microenvironment and thereby promote their own expansion by suppressing cellular immunity. B-cells have proved to be upregulated in large-cell transformed mycosis fungoides, and could potentially play a role in disease progression. To investigate the presence of B-cells in mycosis fungoides compared with controls, this study analysed 85 formalin-fixed and paraffin-embedded mycosis fungoides biopsies. MS4A1 gene expression was significantly upregulated in mycosis fungoides compared with controls (p < 0.0001) and further upregulated in disease progression, (p = 0.001). Digital quantification of PAX5+/ CD20+ cells confirmed the increased presence of Bcells in mycosis fungoides compared with controls. No co-labelling of CD3/CD20 was observed in the neoplastic T-cells. This study found a significantly increased presence of B-cells in the tumour-associated microenvironment in mycosis fungoides. These findings could potentially lead to new treatment strategies for mycosis fungoides.

Original languageEnglish
Article numberadv00413
JournalActa Dermato-Venereologica
Volume101
Issue number3
ISSN0001-5555
DOIs
Publication statusPublished - 11. Mar 2021

Bibliographical note

Publisher Copyright:
© 2021, Medical Journals/Acta D-V. All rights reserved.

Funding

LMRG has received funding from NanoString Technologies. T.L. is employed both by Copenhagen University and by LEO Pharma A/S. The remaining authors have no conflicts of interest to declare. This work was supported by the Danish Cancer Research Foundation (Dansk Kræftforskningsfond), Region Zealand Health and Research Foundation, the Region of Zealand and Southern Denmark Research Foundation, Aage Bang Foundation, LINAK A/S Nordborg, the Harboe Foundation, the carpenter Jørgen Holm and wife Elisa F. Hansen Memorial Foundation, the Medical Research Association Foundation and the A.P. Moeller Foundation. The technical assistance provided by the immunohistochemical and molecular team at the Department of Pathology, N?stved, Denmark is greatly appreciated. This work was supported by the Danish Cancer Research Foundation (Dansk Kr?ftforskningsfond), Region Zealand Health and Research Foundation, the Region of Zealand and Southern Denmark Research Foundation, Aage Bang Foundation, LINAK A/S Nordborg, the Harboe Foundation, the carpenter J?rgen Holm and wife Elisa F. Hansen Memorial Foundation, the Medical Research Association Foundation and the A.P. Moeller Foundation. LMRG has received funding from NanoString Technologies. T.L. is employed both by Copenhagen University and by LEO Pharma A/S. The remaining authors have no conflicts of interest to declare.

Keywords

  • B-cells
  • Cutaneous t-cell lymphoma
  • Mycosis fungoides
  • Tumour microenvironment

Fingerprint

Dive into the research topics of 'Role of B-cells in mycosis fungoides'. Together they form a unique fingerprint.

Cite this